Instituto de Biomedicina de Valencia (CSIC), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Jaime Roig 11, 46010 Valencia, Spain.
IIS Fundación Jiménez Díaz, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28040 Madrid, Spain.
Int J Mol Sci. 2021 May 19;22(10):5351. doi: 10.3390/ijms22105351.
Metformin is a drug in the family of biguanide compounds that is widely used in the treatment of type 2 diabetes (T2D). Interestingly, the therapeutic potential of metformin expands its prescribed use as an anti-diabetic drug. In this sense, it has been described that metformin administration has beneficial effects on different neurological conditions. In this work, we review the beneficial effects of this drug as a neuroprotective agent in different neurological diseases, with a special focus on epileptic disorders and Lafora disease, a particular type of progressive myoclonus epilepsy. In addition, we review the different proposed mechanisms of action of metformin to understand its function at the neurological level.
二甲双胍是一种广泛用于治疗 2 型糖尿病 (T2D) 的双胍类化合物药物。有趣的是,二甲双胍的治疗潜力扩展了其作为抗糖尿病药物的规定用途。从这个意义上说,已经描述了二甲双胍的给药对不同的神经疾病有有益的影响。在这项工作中,我们回顾了这种药物作为一种神经保护剂在不同神经疾病中的有益作用,特别关注癫痫疾病和 Lafora 病,这是一种特殊类型的进行性肌阵挛癫痫。此外,我们还回顾了二甲双胍的不同拟议作用机制,以了解其在神经水平上的功能。